Form Type: 4

SEC EDGAR Link
Accession Number:0001790300-21-000010
Date:2021-07-22
Issuer: RESHAPE LIFESCIENCES INC. (RSLS)
Original Submission Date:

Reporting Person:

STANKOVICH THOMAS
1001 CALLE AMANECER
SAN CLEMENTE, CA 92673

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK, $0.001 PAR VALUE PER SHARE 2021-07-22 A 282,382 a $0.00 315,995 direct
COMMON STOCK, $0.001 PAR VALUE PER SHARE 2021-07-22 A 90,362 a $0.00 406,357 direct
COMMON STOCK, $0.001 PAR VALUE PER SHARE 2021-09-10 S 48,366 d $2.89 357,991 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 these shares will vest and be issued with respect to 123,542 shares on july 22, 2021 and the remaining shares vesting monthly thereafter for 36 months pursuant to a restricted stock unit granted under the reshape lifesciences inc. second amended and restated 2003 stock incentive plan.
f2 these shares will vest and be issued monthly over 36 months beginning on july 22, 2021 pursuant to a restricted stock unit granted under the reshape lifesciences inc. second amended and restated 2003 stock incentive plan.
f3 these shares were sold to cover taxes in connection with the vesting of restricted stock units.
f4 the price reported is a weighted average price. these shares were sold in multiple transactions at prices ranging from $2.88 to $2.90, inclusive. the reporting person undertakes to provide to reshape lifesciences inc., any security holder of reshape lifesciences inc., or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this form 4.
WhaleWisdom Logo

Elevate your investments